Feature Channels: Blood

Filters close
Newswise: hahn_theresa_landscape.jpg
Released: 20-Sep-2024 10:05 AM EDT
Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals
Roswell Park Comprehensive Cancer Center

Open Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals configuration options Historically, some patients with blood cancers have been less likely than others to receive stem cell transplant, also known as bone marrow transplant.

Newswise: UAlbany Researchers Identify New Driver of Antimicrobial Resistance
Released: 20-Sep-2024 9:05 AM EDT
UAlbany Researchers Identify New Driver of Antimicrobial Resistance
University at Albany, State University of New York

UAlbany researchers have identified a genetic mechanism that allows antimicrobial resistance to spread among Klebsiella pneumoniae — the third leading cause of blood infections globally.

Newswise: Channeling Challenge Into Community: Hunter’s Story
Released: 20-Sep-2024 6:05 AM EDT
Channeling Challenge Into Community: Hunter’s Story
Children's Hospital Los Angeles

Hunter doesn’t remember much from his time at Children’s Hospital Los Angeles, but more than a decade later, one small moment has stuck with him in multiple ways.A blonde woman asks him: “She’d hold up an array of ChapSticks,” Hunter explains, “blueberry, strawberry, green apple, root beer float and chocolate.”

access_time Embargo lifts in 2 days
This news release is embargoed until 23-Sep-2024 5:00 PM EDT Released to reporters: 19-Sep-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Cleveland Clinic Study Is First to Show Success in Treating Rare Blood Disorder
13-Sep-2024 10:05 AM EDT
Cleveland Clinic Study Is First to Show Success in Treating Rare Blood Disorder
Cleveland Clinic

CLEVELAND: A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in 5,000 people worldwide.

Newswise:Video Embedded kidney-health-insights-live-expert-panel-on-managing-obesity-in-kidney-disease
VIDEO
17-Sep-2024 7:05 AM EDT
Video and Transcript Available: Obesity Management and Kidney Health: Live Expert Panel
Newswise

Reporters are invited to this live event on Obesity Management and Kidney Health. Experts from the American Society of Nephrology will take questions on the inaugural Kidney Health Guidance on managing obesity in kidney disease patients

       
Newswise: Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma
Released: 17-Sep-2024 10:05 AM EDT
Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma
Roswell Park Comprehensive Cancer Center

A significant number of multiple myeloma patients may have an inherited but previously unrecognized risk of developing the disease, a new study led by Roswell Park Chief of Clinical Genomics Kenan Onel, MD, PhD, reveals.

Released: 17-Sep-2024 7:30 AM EDT
Risk of Clots, Stroke From Incorrect Blood Thinner Dosing Reduced Using Online Dashboard
Michigan Medicine - University of Michigan

Doctors and pharmacists treating people with blood thinners can reduce the rate of inappropriate dosing — as well as blood clots and strokes that can result from it — using an electronic patient management system, a study suggests. Direct oral anticoagulants can be incorrectly prescribed up to 20% of the time.

Released: 16-Sep-2024 2:05 PM EDT
Estudo da Mayo Clinic descobre glóbulos brancos disfuncionais ligados ao aumento do risco de melanoma
Mayo Clinic

Pessoas com uma superabundância de glóbulos brancos clonados, ou linfócitos, que prejudicam o seu sistema imunológico — uma condição chamada linfocitose monoclonal de células B (LMB) — podem apresentar um risco elevado de desenvolver várias complicações de saúde, incluindo o melanoma, uma forma de câncer de pele.

Released: 16-Sep-2024 12:05 PM EDT
Estudio De Mayo Clinic Encuentra GlóBulos Blancos Disfuncionales Relacionados Con Un Mayor Riesgo De Melanoma
Mayo Clinic

Personas con una sobreabundancia de glóbulos blancos clonados, o linfocitos, que dañan su sistema inmunológico, una afección llamada linfocitosis monoclonal de células B (LMB), pueden tener un riesgo elevado de desarrollar diversas complicaciones de salud, incluido el melanoma, una forma de cáncer de piel.

Released: 16-Sep-2024 12:05 PM EDT
Testing a Revolutionary Treatment Against Progressive Multiple Sclerosis
Rutgers University-New Brunswick

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease.

Newswise: News Tip: September Is Sickle Cell Awareness Month – Johns Hopkins Medicine Experts Are Available for Interviews
Released: 16-Sep-2024 10:05 AM EDT
News Tip: September Is Sickle Cell Awareness Month – Johns Hopkins Medicine Experts Are Available for Interviews
Johns Hopkins Medicine

September is National Sickle Cell Awareness Month. Experts from Johns Hopkins Medicine who specialize in sickle cell disease are available to discuss health equity issues related to sickle cell disease.

Released: 16-Sep-2024 8:05 AM EDT
Argon Medical Launches CLEANER Vac™ Thrombectomy System to Remove Blood Clot in the Peripheral Venous Vasculature
Argon Medical Devices, Inc.

Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the CLEANER Vac™ Thrombectomy System for the removal of blood clot from the peripheral venous vasculature.

13-Sep-2024 12:05 PM EDT
Researchers Discover New Blood Group System – MAL
University of Bristol

The discovery of a new blood group, MAL, has solved a 50- year-old mystery. The findings allow identification and treatment of rare patients lacking this blood group.

Newswise:Video Embedded hypertension-disrupts-natural-blood-pressure-dipping-rhythm-in-both-sexes
VIDEO
Released: 11-Sep-2024 10:30 AM EDT
Hypertension Disrupts Natural Blood Pressure ‘Dipping’ Rhythm in Both Sexes
American Physiological Society (APS)

High blood pressure disrupts natural day-and-night blood pressure dipping patterns in males and females, according to a new study from Tulane University School of Medicine.

Newswise: Pausing Biological Clock Could Boost Lab-Produced Blood Stem Cells
Released: 9-Sep-2024 4:05 PM EDT
Pausing Biological Clock Could Boost Lab-Produced Blood Stem Cells
Iowa State University

An Iowa State University research team has discovered when and why inflammatory signaling affects the formation of blood stem cells in embryos, which will benefit efforts to develop lab-grown, patient-derived stem cell transfusions to treat blood disorders. The promising advancement in regenerative medicine could eliminate the need for bone marrow transplants.

Newswise: New Study Seeks to Develop a New Treatment Strategy to Prevent/Delay Relapse of Myeloid Leukemia Associated with Down Syndrome
Released: 9-Sep-2024 2:05 PM EDT
New Study Seeks to Develop a New Treatment Strategy to Prevent/Delay Relapse of Myeloid Leukemia Associated with Down Syndrome
Wayne State University Division of Research

A four-year, $1.2 million grant from the National Cancer Institute of the National Institutes of Health to Wayne State University may help researchers find new clues to the interplay between Down syndrome and myeloid leukemia.

Released: 6-Sep-2024 12:05 PM EDT
Medical Students Explore a Future in Research Through the Summer Oncology Research Fellowship Program
Children's Hospital Los Angeles

For many students, summer break represents an opportunity for relaxation and carefree vacations. But for the medical students taking part in the USC/CHLA Summer Oncology Research Fellowship (SORF) Program, summer means something more

Newswise: Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma
4-Sep-2024 10:00 AM EDT
Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma
Johns Hopkins Medicine

Age-related changes in the fibroblasts, cells that create the skin’s structure, contribute to the development of aggressive, treatment-resistant melanoma in males, according to research in mice by the Johns Hopkins Kimmel Cancer Center.



close
2.63501